Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU device definition

This article was originally published in The Gray Sheet

Executive Summary

European Parliament votes Oct. 2 to define pharmaceuticals as substances that may be "used in" human beings instead of "administered to," as proposed in original pharmaceutical directive review legislation. The words "by exerting a pharmacological action" have been added, however, and Eucomed will lobby to insert "as primary mode of action" into the text. European industry reps have been wary of the definition since summer, when concerns first surfaced that combination products would automatically be legislated as drugs (1"The Gray Sheet" June 24, 2002, p. 12)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017296

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel